Clinical Trial Update: Utilizing Private Pharmacies to Initiate High-risk Young Individuals on PrEP in South Africa [Phase 4]

View source ↗

Summary

Phase 4 trial update examining initiation of HIV pre-exposure prophylaxis (PrEP) for high-risk young individuals through private pharmacies in South Africa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Professor Francois Venter | Conditions: HIV Infection | Phase 4 | Status: ACTIVE_NOT_RECRUITING